PCM
EBS icon

Price Capital Management’s Emergent Biosolutions EBS Stock Holding History

Price Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,374
Closed -$241K – 76
2015
Q1 		$241K Buy
+8,374
New +$240K 0.15% 159

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Price Capital Management's EBS Position: Q2 2015 in Review

Price Capital Management sold out of Emergent Biosolutions (EBS) in Q2 2015, closing a stake of 8,374 shares — an estimated $241K sold.

Price Capital Management first reported a position in EBS in Q1 2015 and held it in 1 quarter. The position peaked at $241K in Q1 2015. 184 funds tracked by Wall St. Rank hold EBS as of Q2 2015.

  • Price Capital Management reported no remaining Emergent Biosolutions position as of Q2 2015 after selling out during the quarter.
  • Price Capital Management sold 8,374 Emergent Biosolutions shares in Q2 2015, an estimated $241K.
  • Price Capital Management first reported a position in Emergent Biosolutions in Q1 2015 and held it in 1 quarter.
  • Price Capital Management's Emergent Biosolutions position peaked at $241K in Q1 2015.
  • 184 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2015.

Based on Price Capital Management's 13F filing for Q2 2015.